Arch Therapeutics, Inc.
Save
5.60M
Market cap
–
Current P/E
0.11x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds.
Similar securities
Based on sector and market capitalization
Report issue